Vidaza

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

GSK’s overhaul begins under new CEO; Sandoz loses US$ 940 million lawsuit

This week, Phispers brings you news on GSK, whose new CEO is planning a slew of initiatives to make

Dr. Reddy’s expansion plans for API production

Unrelated to the inspection of the USFDA at the Dr. Reddys Srikakulam facility, Dr. Reddys sought pe